Nuvation Bio's total assets for Q4 2024 were $540.63M, a decrease of -5.42% from the previous quarter. NUVB total liabilities were $76.84M for the fiscal quarter, a 11.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.